Skip to main content
Premium Trial:

Request an Annual Quote

Uppsala Bio-Development Group Offering $3M Per Year for Dx, Rx Projects

NEW YORK (GenomeWeb News) — Swedish bio-development organization Uppsala Bio is putting out a call for new multi-disciplinary projects for the company’s BIO-X program, which promotes research projects in the Uppsala region, the group said last week.
 
Uppsala said the new project will be funded with SEK 2 million ($2.8 million) per year, and will receive “substantial management and IP support, as well as access to a broad network of industrial and academic expertise.” 
 
The organization seeks projects involving diagnostic tools and predictive medicinal projects and early or late-stage drug-discovery programs.
 
Uppsala said its projects to date have started in academia, but said it is interested in industry-initiated efforts that through collaboration with academic groups.
 
Submissions are due April 10.
 
More information is available at Uppsala Bio’s website.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.